1
|
Tähtinen V, Gulumkar V, Maity SK, Yliperttula AM, Siekkinen S, Laine T, Lisitsyna E, Haapalehto I, Viitala T, Vuorimaa-Laukkanen E, Yliperttula M, Virta P. Assembly of Bleomycin Saccharide-Decorated Spherical Nucleic Acids. Bioconjug Chem 2022; 33:206-218. [PMID: 34985282 PMCID: PMC8778632 DOI: 10.1021/acs.bioconjchem.1c00539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Glyco-decorated spherical nucleic acids (SNAs) may be attractive delivery vehicles, emphasizing the sugar-specific effect on the outer sphere of the construct and at the same time hiding unfavorable distribution properties of the loaded oligonucleotides. As examples of such nanoparticles, tripodal sugar constituents of bleomycin were synthesized and conjugated with a fluorescence-labeled antisense oligonucleotide (AONARV7). Successive copper(I)-catalyzed azide-alkyne and strain-promoted alkyne-nitrone cycloadditions (SPANC) were utilized for the synthesis. Then, the glyco-AONARV7 conjugates were hybridized with complementary strands of a C60-based molecular spherical nucleic acid (i.e., a hybridization-mediated carrier). The formation and stability of these assembled glyco-decorated SNAs were evaluated by polyacrylamide gel electrophoresis (PAGE), UV melting profile analysis, and time-resolved fluorescence spectroscopy. Association constants were extracted from time-resolved fluorescence data. Preliminary cellular uptake experiments of the glyco-AONARV7 conjugates (120 nM solutions) and of the corresponding glyco-decorated SNAs (10 nM solutions) with human prostate cancer cells (PC3) showed an efficient uptake in each case. A marked variation in intracellular distribution was observed.
Collapse
Affiliation(s)
- Ville Tähtinen
- Department of Chemistry, University of Turku, FI-20500 Turku, Finland
| | - Vijay Gulumkar
- Department of Chemistry, University of Turku, FI-20500 Turku, Finland
| | - Sajal K Maity
- Department of Chemistry, University of Turku, FI-20500 Turku, Finland
| | - Ann-Mari Yliperttula
- Department of Chemistry, University of Turku, FI-20500 Turku, Finland.,Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland
| | - Saara Siekkinen
- Department of Chemistry, University of Turku, FI-20500 Turku, Finland.,Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland
| | - Toni Laine
- Department of Chemistry, University of Turku, FI-20500 Turku, Finland
| | - Ekaterina Lisitsyna
- Faculty of Engineering and Natural Sciences, Tampere University, FI-33014 Tampere, Finland
| | - Iida Haapalehto
- Faculty of Engineering and Natural Sciences, Tampere University, FI-33014 Tampere, Finland
| | - Tapani Viitala
- Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland.,Pharmaceutical Sciences, Faculty of Science and Engineering, Åbo Akademi University, 20520 Turku, Finland
| | | | - Marjo Yliperttula
- Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland
| | - Pasi Virta
- Department of Chemistry, University of Turku, FI-20500 Turku, Finland
| |
Collapse
|
2
|
Schroeder BR, Ghare MI, Bhattacharya C, Paul R, Yu Z, Zaleski PA, Bozeman TC, Rishel MJ, Hecht SM. The disaccharide moiety of bleomycin facilitates uptake by cancer cells. J Am Chem Soc 2014; 136:13641-56. [PMID: 25184545 PMCID: PMC4183664 DOI: 10.1021/ja507255g] [Citation(s) in RCA: 91] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
![]()
The disaccharide moiety is responsible
for the tumor cell targeting
properties of bleomycin (BLM). While the aglycon (deglycobleomycin)
mediates DNA cleavage in much the same fashion as bleomycin, it exhibits
diminished cytotoxicity in comparison to BLM. These findings suggested
that BLM might be modular in nature, composed of tumor-seeking and
tumoricidal domains. To explore this possibility, BLM analogues were
prepared in which the disaccharide moiety was attached to deglycobleomycin
at novel positions, namely, via the threonine moiety or C-terminal
substituent. The analogues were compared with BLM and deglycoBLM for
DNA cleavage, cancer cell uptake, and cytotoxic activity. BLM is more
potent than deglycoBLM in supercoiled plasmid DNA relaxation, while
the analogue having the disaccharide on threonine was less active
than deglycoBLM and the analogue containing the C-terminal disaccharide
was slightly more potent. While having unexceptional DNA cleavage
potencies, both glycosylated analogues were more cytotoxic to cultured
DU145 prostate cancer cells than deglycoBLM. Dye-labeled conjugates
of the cytotoxic BLM aglycons were used in imaging experiments to
determine the extent of cell uptake. The rank order of internalization
efficiencies was the same as their order of cytotoxicities toward
DU145 cells. These findings establish a role for the BLM disaccharide
in tumor targeting/uptake and suggest that the disaccharide moiety
may be capable of delivering other cytotoxins to cancer cells. While
the mechanism responsible for uptake of the BLM disaccharide selectively
by tumor cells has not yet been established, data are presented which
suggest that the metabolic shift to glycolysis in cancer cells may
provide the vehicle for selective internalization.
Collapse
Affiliation(s)
- Benjamin R Schroeder
- Department of Chemistry, University of Virginia , Charlottesville, Virginia 22904, United States
| | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Cai X, Zaleski PA, Cagir A, Hecht SM. Deglycobleomycin A6 analogues modified in the methylvalerate moiety. Bioorg Med Chem 2011; 19:3831-44. [DOI: 10.1016/j.bmc.2011.04.047] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2011] [Revised: 04/22/2011] [Accepted: 04/25/2011] [Indexed: 10/18/2022]
|
4
|
Nandy JP, Prakesch M, Khadem S, Reddy PT, Sharma U, Arya P. Advances in Solution- and Solid-Phase Synthesis toward the Generation of Natural Product-like Libraries. Chem Rev 2009; 109:1999-2060. [DOI: 10.1021/cr800188v] [Citation(s) in RCA: 151] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Jyoti P. Nandy
- Ontario Institute for Cancer Research, MaRS Centre, South Tower, 101 College Street, Toronto, Ontario M5G 1L7, Canada, Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, Ontario K1A 0R6, Canada, and Department of Chemistry, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada
| | - Michael Prakesch
- Ontario Institute for Cancer Research, MaRS Centre, South Tower, 101 College Street, Toronto, Ontario M5G 1L7, Canada, Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, Ontario K1A 0R6, Canada, and Department of Chemistry, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada
| | - Shahriar Khadem
- Ontario Institute for Cancer Research, MaRS Centre, South Tower, 101 College Street, Toronto, Ontario M5G 1L7, Canada, Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, Ontario K1A 0R6, Canada, and Department of Chemistry, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada
| | - P. Thirupathi Reddy
- Ontario Institute for Cancer Research, MaRS Centre, South Tower, 101 College Street, Toronto, Ontario M5G 1L7, Canada, Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, Ontario K1A 0R6, Canada, and Department of Chemistry, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada
| | - Utpal Sharma
- Ontario Institute for Cancer Research, MaRS Centre, South Tower, 101 College Street, Toronto, Ontario M5G 1L7, Canada, Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, Ontario K1A 0R6, Canada, and Department of Chemistry, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada
| | - Prabhat Arya
- Ontario Institute for Cancer Research, MaRS Centre, South Tower, 101 College Street, Toronto, Ontario M5G 1L7, Canada, Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, Ontario K1A 0R6, Canada, and Department of Chemistry, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada
| |
Collapse
|
5
|
Akiyama Y, Ma Q, Edgar E, Laikhter A, Hecht SM. A Novel DNA Hairpin Substrate for Bleomycin. Org Lett 2008; 10:2127-30. [DOI: 10.1021/ol800445x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Yoshitsugu Akiyama
- Departments of Chemistry and Biology, University of Virginia, Charlottesville, Virginia 22904, and Integrated DNA Technologies, 1710 Commercial Park, Coralville, Iowa 52241
| | - Qian Ma
- Departments of Chemistry and Biology, University of Virginia, Charlottesville, Virginia 22904, and Integrated DNA Technologies, 1710 Commercial Park, Coralville, Iowa 52241
| | - Erin Edgar
- Departments of Chemistry and Biology, University of Virginia, Charlottesville, Virginia 22904, and Integrated DNA Technologies, 1710 Commercial Park, Coralville, Iowa 52241
| | - Andrei Laikhter
- Departments of Chemistry and Biology, University of Virginia, Charlottesville, Virginia 22904, and Integrated DNA Technologies, 1710 Commercial Park, Coralville, Iowa 52241
| | - Sidney M. Hecht
- Departments of Chemistry and Biology, University of Virginia, Charlottesville, Virginia 22904, and Integrated DNA Technologies, 1710 Commercial Park, Coralville, Iowa 52241
| |
Collapse
|
6
|
Ma Q, Xu Z, Schroeder BR, Sun W, Wei F, Hashimoto S, Konishi K, Leitheiser CJ, Hecht SM. Biochemical evaluation of a 108-member deglycobleomycin library: viability of a selection strategy for identifying bleomycin analogues with altered properties. J Am Chem Soc 2007; 129:12439-52. [PMID: 17887752 DOI: 10.1021/ja0722729] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The bleomycins (BLMs) are clinically used glycopeptide antitumor antibiotics that have been shown to mediate the sequence-selective oxidative damage of both DNA and RNA. Previously, we described the solid-phase synthesis of a library of 108 unique analogues of deglycoBLM A6, a congener that cleaves DNA analogously to BLM itself. Each member of the library was assayed for its ability to effect single- and double-strand nicking of duplex DNA, sequence-selective DNA cleavage, and RNA cleavage in the presence and absence of a metal ion cofactor. All of the analogues tested were found to mediate concentration-dependent plasmid DNA relaxation to some extent, and a number exhibited double-strand cleavage with an efficiency comparable to or greater than deglycoBLM A6. Further, some analogues having altered linker and metal-binding domains mediated altered sequence-selective cleavage, and a few were found to cleave a tRNA3Lys transcript both in the presence and in the absence of a metal cofactor. The results provide insights into structural elements within BLM that control DNA and RNA cleavage. The present study also permits inferences to be drawn regarding the practicality of a selection strategy for the solid-phase construction and evaluation of large libraries of BLM analogues having altered properties.
Collapse
Affiliation(s)
- Qian Ma
- Departments of Chemistry and Biology, University of Virginia, Charlottesville, Virginia 22904, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Wang L, Yun BS, George NP, Wendt-Pienkowski E, Galm U, Oh TJ, Coughlin JM, Zhang G, Tao M, Shen B. Glycopeptide antitumor antibiotic zorbamycin from Streptomyces flavoviridis ATCC 21892: strain improvement and structure elucidation. JOURNAL OF NATURAL PRODUCTS 2007; 70:402-6. [PMID: 17311457 PMCID: PMC2579990 DOI: 10.1021/np060592k] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
Zorbamycin (1, ZBM) is a glycopeptide antitumor antibiotic first reported in 1971. The partial structures of 1 were speculated on the basis of its acid hydrolysis products, but the structure of the intact molecule has never been established. The low titer of 1 from the wild-type strain, combined with its acid-instability, has so far hampered its isolation. By random mutagenesis of Streptomyces flavoviridis ATCC21892, a wild-type producer of 1, with UV irradiation, two high-producing strains of 1, S. flavoviridis SB9000 and SB9001, were isolated. Under the optimized fermentation conditions, these two strains produced about 10 mg/L of 1, which was about 10-fold higher than the wild-type ATCC21892 strain, as estimated by HPLC analysis. Finally, 1 was isolated as both a 1-Cu complex and Cu-free molecule, and the intact structure of 1 was established on the basis of a combination of mass spectrometry and 1H and 13C NMR spectroscopic analyses.
Collapse
Affiliation(s)
- Liyan Wang
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI 53705
| | - Bong-Sik Yun
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI 53705
| | - Nicholas P. George
- Microbiology Doctoral Training Program, University of Wisconsin-Madison, Madison, WI 53705
| | | | - Ute Galm
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI 53705
| | - Tae-Jin Oh
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI 53705
| | - Jane M. Coughlin
- Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53705
| | - Guodong Zhang
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI 53705
| | - Meifeng Tao
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI 53705
| | - Ben Shen
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI 53705
- Microbiology Doctoral Training Program, University of Wisconsin-Madison, Madison, WI 53705
- Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53705
- University of Wisconsin National Cooperative Drug Discovery Group, University of Wisconsin-Madison, Madison, WI 53705
- To whom correspondence should be addressed: Tel: (608) 263-2673. Fax: (608) 262-5345. E-mail:
| |
Collapse
|
8
|
Galm U, Hager MH, Van Lanen SG, Ju J, Thorson JS, Shen B. Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin. Chem Rev 2005; 105:739-58. [PMID: 15700963 DOI: 10.1021/cr030117g] [Citation(s) in RCA: 417] [Impact Index Per Article: 21.9] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Ute Galm
- Division of Pharmaceutical Sciences and Department of Chemistry, University of Wisconsin, Madison, Wisconsin 53705, USA
| | | | | | | | | | | |
Collapse
|
9
|
Aouida M, Leduc A, Wang H, Ramotar D. Characterization of a transport and detoxification pathway for the antitumour drug bleomycin in Saccharomyces cerevisiae. Biochem J 2004; 384:47-58. [PMID: 15248838 PMCID: PMC1134087 DOI: 10.1042/bj20040392] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2004] [Revised: 06/17/2004] [Accepted: 07/13/2004] [Indexed: 11/17/2022]
Abstract
BLM (bleomycin) is effective in combination therapy against various cancers including testicular cancer. However, several other cancers such as colon cancer are refractory to BLM treatment. The exact mechanism for this differential response of cancer cells to the drug is not known. In the present study, we created fluorescently labelled BLM-A5, which retained nearly full genotoxic potential, and used this molecule to conduct the first study to understand the transport pathway of the drug in Saccharomyces cerevisiae. Uptake studies revealed that fluoro-BLM-A5 is transported into the cell in a concentration-dependent manner. Transport of a non-saturating concentration of fluoro-BLM-A5 was modest for the first 90 min, but thereafter it was sharply induced until 300 min. The inducible transport was completely abolished by the addition of cycloheximide, suggesting that BLM-A5 uptake into the cell is dependent on new protein synthesis. Interestingly, transport of fluoro-BLM-A5 was blocked if the cells were preincubated with increasing concentrations of spermine. Moreover, a mutant lacking the Ptk2 kinase, necessary for positively regulating polyamine transport, was defective in fluoro-BLM-A5 uptake and exhibited extreme resistance to the drug. A simple interpretation of these results is that BLM-A5 may enter the cell through the polyamine transport system. We showed further that after the uptake, fluoro-BLM-A5 accumulated into the vacuole of the parent, but localized to the cytoplasm of mutants disrupted for the END3 gene required for an early step of the endocytotic pathway. In general, mutants with a defect in the endocytic pathway to the vacuole were hypersensitive to BLM-A5. We suggest that BLM-A5 is transported across the yeast plasma membrane and sequestered into the vacuole for detoxification.
Collapse
Affiliation(s)
- Mustapha Aouida
- Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, University of Montreal, 5415, Boul. de l'Assomption, Montreal, Quebec, Canada H1T 2M4
| | - Anick Leduc
- Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, University of Montreal, 5415, Boul. de l'Assomption, Montreal, Quebec, Canada H1T 2M4
| | - Huijie Wang
- Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, University of Montreal, 5415, Boul. de l'Assomption, Montreal, Quebec, Canada H1T 2M4
| | - Dindial Ramotar
- Guy-Bernier Research Center, Maisonneuve-Rosemont Hospital, University of Montreal, 5415, Boul. de l'Assomption, Montreal, Quebec, Canada H1T 2M4
| |
Collapse
|
10
|
Cagir A, Tao ZF, Sucheck SJ, Hecht SM. Solid-phase synthesis and biochemical evaluation of conformationally constrained analogues of deglycobleomycin A5. Bioorg Med Chem 2003; 11:5179-87. [PMID: 14604681 DOI: 10.1016/j.bmc.2003.08.033] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Deglycobleomycin binds to and degrades the self-complementary oligonucleotide d(CGCTAGCG)(2) in a sequence selective fashion. A previous modeling study [J. Am. Chem. Soc. 120, (1998), 7450] had shown that, during binding to double stranded DNA, the conformation of the methylvalerate domain of deglycoBLM approximated that of S-proline. In the belief that an analogue of deglycoBLM structurally constrained to mimic the DNA-bound conformation might exhibit facilitated DNA binding and cleavage, an analogue of deglycoBLM was prepared in which the methylvalerate moiety was replaced by S-proline. This deglycoBLM analogue, as well as the related analogue containing R-proline, was synthesized on a TentaGel resin. Both of the analogues were found to be capable of binding Fe(2+) and activating O(2) for transfer to styrene. However, both deglycoBLM analogues exhibited diminished abilities to effect the relaxation of supercoiled plasmid DNA, and neither mediated sequence selective DNA cleavage.
Collapse
Affiliation(s)
- Ali Cagir
- Departments of Chemistry and Biology, University of Virginia, Charlottesville, VA 22901, USA
| | | | | | | |
Collapse
|
11
|
Rishel MJ, Thomas CJ, Tao ZF, Vialas C, Leitheiser CJ, Hecht SM. Conformationally constrained analogues of bleomycin A5. J Am Chem Soc 2003; 125:10194-205. [PMID: 12926941 DOI: 10.1021/ja030057w] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The bleomycin (BLM) group antitumor antibiotics are glycopeptide-derived natural products shown to cause sequence selective lesions in DNA. Prior studies have indicated that the linker region, composed of the methylvalerate and threonine residues, may be responsible for a conformational bend in the agent required for efficient DNA cleavage. We have synthesized a number of conformationally constrained methylvalerate analogues and incorporated them into deglycobleomycin A(5) congeners using our recently reported procedure for the solid phase construction of (deglyco)bleomycin and its analogues. These analogues were designed to probe the effects of conformational constraint of the native valerate moiety. Initial experiments indicated that the constrained molecules, none of which mimic the conformation proposed for the natural valerate linker, possessed DNA cleavage activity, albeit with potencies less than that of (deglyco)BLM and lacking sequence selectivity. Further experiments demonstrated that these analogues failed to produce alkali-labile lesions in DNA or sequence selective oxidative damage in RNA. However, two of the conformationally constrained deglycoBLM analogues were shown to mediate RNA cleavage in the absence of added Fe(2+). The ability of the analogues to mediate the oxygenation of small molecules was also assayed, and it was shown that they were as competent in the transfer of oxygen to low molecular weight substrates as the parent compound.
Collapse
Affiliation(s)
- Michael J Rishel
- Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA
| | | | | | | | | | | |
Collapse
|
12
|
Leitheiser CJ, Smith KL, Rishel MJ, Hashimoto S, Konishi K, Thomas CJ, Li C, McCormick MM, Hecht SM. Solid-phase synthesis of bleomycin group antibiotics. Construction of a 108-member deglycobleomycin library. J Am Chem Soc 2003; 125:8218-27. [PMID: 12837092 DOI: 10.1021/ja021388w] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The bleomycins (BLMs) are structurally related glycopeptide antibiotics isolated from Streptomyces verticillus that mediate the sequence-selective oxidative damage of DNA and RNA. Deglycobleomycin, which lacks the carbohydrate moiety, cleaves DNA analogously to bleomycin itself, albeit less potently, and has been used successfully for analyzing the functional domains of bleomycin. Although structural modifications to bleomycin and deglycobleomycin have been reported, no bleomycin or deglycobleomycin analogue having enhanced DNA cleavage activity has yet been described. The successful synthesis of a deglycobleomycin on a solid support has permitted the facile solid-phase synthesis of 108 unique deglycobleomycin analogues through parallel solid-phase synthesis. Each of the deglycobleomycin analogues was synthesized efficiently; the purity of each crude product was greater than 60%, as determined by HPLC integration. The solid-phase synthesis of the deglycobleomycin library provided near-milligram to milligram quantities of each deglycobleomycin, thereby permitting characterization by (1)H NMR and high-resolution mass spectrometry. Each analogue demonstrated supercoiled plasmid DNA relaxation above background cleavage; the library included two analogues that mediated plasmid relaxation to a greater extent than the parent deglycobleomycin molecule.
Collapse
|
13
|
Ramotar D, Wang H. Protective mechanisms against the antitumor agent bleomycin: lessons from Saccharomyces cerevisiae. Curr Genet 2003; 43:213-24. [PMID: 12698269 DOI: 10.1007/s00294-003-0396-1] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2003] [Revised: 03/17/2003] [Accepted: 03/18/2003] [Indexed: 10/26/2022]
Abstract
Bleomycin is a small glycopeptide antibiotic used in combination therapy for the treatment of a few types of human cancer. The antitumor effect of bleomycin is most likely caused by its ability to bind to DNA and induce the formation of toxic DNA lesions via a free radical reactive (Fe.bleomycin) complex. However, the chemotherapeutic potential of bleomycin is limited, as it causes pulmonary fibrosis and tumor resistance at high doses. The chemical structure and modes of action of bleomycin have been extensively studied and these provide a foundation towards improving the therapeutic value of the drug. This review provides a first account of the current state of knowledge of the cellular processes that can allow the yeast Saccharomyces cerevisiae to evade the lethal effects of bleomycin. This model organism is likely to provide rapid clues in our understanding of bleomycin resistance in tumor cells.
Collapse
Affiliation(s)
- Dindial Ramotar
- Maisonneuve-Rosemont Hospital, Guy-Bernier Research Center, 5415 Boulevard de l'Assomption, H1T 2M4, Montreal, Quebec, Canada.
| | | |
Collapse
|
14
|
Thomas CJ, Chizhov AO, Leitheiser CJ, Rishel MJ, Konishi K, Tao ZF, Hecht SM. Solid-phase synthesis of bleomycin A(5) and three monosaccharide analogues: exploring the role of the carbohydrate moiety in RNA cleavage. J Am Chem Soc 2002; 124:12926-7. [PMID: 12405801 DOI: 10.1021/ja0208916] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The solid-phase synthesis of bleomycin A5 (BLM A5) and three monosaccharide analogues is presented. The monosaccharide analogues incorporated alpha-d-mannose, alpha-l-gulose, and alpha-l-rhamnose moieties in lieu of the disaccharide normally present in BLM A5. Also explored were the abilities of each of the monosaccharide congeners to cleave a 53-nt RNA. The elaboration of these carbohydrate-modified bleomycin analogues helps to define the role of the disaccharide moiety during the RNA cleavage event. The relatively facile solid-phase synthesis of bleomycin A5 and each of the carbohydrate analogues constitutes an important advance in the continuing mechanistic studies of bleomycin.
Collapse
Affiliation(s)
- Craig J Thomas
- Department of Chemistry and Biology, University of Virginia, Charlottesville, Virginia 22901, USA
| | | | | | | | | | | | | |
Collapse
|
15
|
Tao ZF, Leitheiser CJ, Smith KL, Hashimoto S, Hecht SM. Solid-phase synthesis of deglycobleomycins: a C-terminal tetraamine linker that permits direct evaluation of resin-bound bleomycins. Bioconjug Chem 2002; 13:426-34. [PMID: 12009930 DOI: 10.1021/bc010083o] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Deglycobleomycin analogues having different length polyamine side chains at the C-terminus were synthesized using a novel solid-phase synthesis strategy that produces fully deprotected deglycobleomycin congeners attached to the resin. Detailed studies of DNA cleavage by these compounds and their resin-bound counterparts using supercoiled plasmid DNAs and DNA restriction fragments as substrates revealed that (i) the length of the polyamine side chain of free deglycoBLM had limited effect on its DNA cleavage potency or sequence selectivity, and (ii) the nature of the linker moiety between the resin and attached deglycobleomycin had a more substantial effect on the potency of DNA cleavage, but no effect on sequence selectivity of resin-bound deglycoBLMs. Resin-bound 4 exhibited efficient DNA cleavage, indicating that its tetraamine linker moiety could be used for the elaboration and direct evaluation of bleomycin congeners attached to resins.
Collapse
Affiliation(s)
- Zhi-Fu Tao
- Department of Chemistry, University of Virginia, Charlottesville 22901, USA
| | | | | | | | | |
Collapse
|
16
|
Thomas CJ, McCormick MM, Vialas C, Tao ZF, Leitheiser CJ, Rishel MJ, Wu X, Hecht SM. Alteration of the selectivity of DNA cleavage by a deglycobleomycin analogue containing a trithiazole moiety. J Am Chem Soc 2002; 124:3875-84. [PMID: 11942824 DOI: 10.1021/ja011820u] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The bleomycin (BLM) group of antitumor antibiotics effects DNA cleavage in a sequence-selective manner. Previous studies have indicated that the metal-binding and bithiazole moieties of BLM are both involved in the binding of BLM to DNA. The metal-binding domain is normally the predominant structural element in determining the sequence selectivity of DNA binding, but it has been shown that replacement of the bithiazole moiety with a strong DNA binder can alter the sequence selectivity of DNA binding and cleavage. To further explore the mechanism by which BLM and DNA interact, a trithiazole-containing deglycoBLM analogue was synthesized and tested for its ability to relax supercoiled DNA and cleave linear duplex DNA in a sequence-selective fashion. Also studied was cleavage of a novel RNA substrate. Solid-phase synthesis of the trithiazole deglycoBLM A(5) analogue was achieved using a TentaGel resin containing a Dde linker and elaborated from five key intermediates. The ability of the resulting BLM analogue to relax supercoiled DNA was largely unaffected by introduction of the additional thiazole moiety. Remarkably, while no new sites of DNA cleavage were observed for this analogue, there was a strong preference for cleavage at two 5'-GT-3' sites when a 5'-(32)P end-labeled DNA duplex was used as a substrate. The alteration of sequence selectivity of cleavage was accompanied by some decrease in the potency of DNA cleavage, albeit without a dramatic diminution. In common with BLM, the trithiazole analogue of deglycoBLM A(5) effected both hydrolytic cleavage of RNA in the absence of added metal ion and oxidative cleavage in the presence of Fe(2+) and O(2). In comparison with BLM A(5), the relative efficiencies of hydrolytic cleavage at individual sites were altered.
Collapse
Affiliation(s)
- Craig J Thomas
- Department of Chemistry, University of Virginia, Charlottesville, Virginia 22901, USA
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Smith KL, Tao ZF, Hashimoto S, Leitheiser CJ, Wu X, Hecht SM. Deglycobleomycin: solid-phase synthesis and DNA cleavage by the resin-bound ligand. Org Lett 2002; 4:1079-82. [PMID: 11922787 DOI: 10.1021/ol010293g] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
[structure: see text] A greatly improved solid-phase synthesis of deglycobleomycin using a Dde-based linker is reported. The resin-bound deglycobleomycin could be completely deblocked and assayed for DNA plasmid relaxation, sequence-selective DNA cleavage, and light production from a molecular beacon.
Collapse
Affiliation(s)
- Kenneth L Smith
- Departments of Chemistry and Biology, University of Virginia, Charlottesville, Virginia 22901, USA
| | | | | | | | | | | |
Collapse
|
18
|
Shen B, Du L, Sanchez C, Edwards DJ, Chen M, Murrell JM. Cloning and characterization of the bleomycin biosynthetic gene cluster from Streptomyces verticillus ATCC15003. JOURNAL OF NATURAL PRODUCTS 2002; 65:422-431. [PMID: 11908996 DOI: 10.1021/np010550q] [Citation(s) in RCA: 59] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Bleomycin (BLM) biosynthesis has been studied as a model for hybrid peptide-polyketide natural product biosynthesis. Cloning, sequencing, and biochemical characterization of the blm biosynthetic gene cluster from Streptomyces verticillus ATCC15003 revealed that (1) the BLM hybrid peptide-polyketide aglycon is assembled by the BLM megasynthetase that consists of both nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) modules; (2) BlmIX/BlmVIII/BlmVII constitute a natural hybrid NRPS/PKS/NRPS system, serving as a model for both hybrid NRPS/PKS and PKS/NRPS systems; (3) the catalytic sites appear to be conserved in both hybrid NRPS/PKS and nonhybrid NRPS or PKS systems, with the exception of the KS domains in the hybrid NRPS/PKS systems that are unique; (4) specific interpolypeptide linkers may play a critical role in intermodular communication to facilitate the transfer of the growing intermediates between the interacting NRPS and/or PKS modules; (5) post-translational modification of the BLM megasynthetase has been accomplished by a single PPTase with broad carrier protein specificity; and (6) BlmIV/BlmIII-templated assembly of the BLM bithiazole moiety requires intriguing protein juxtaposition and modular recognition. These results lay the foundation to investigate the molecular basis for intermodular communication between NRPS and PKS in hybrid peptide-polyketide natural product biosynthesis and set the stage for engineering novel BLM analogues by genetic manipulation of genes governing BLM biosynthesis.
Collapse
Affiliation(s)
- Ben Shen
- Department of Chemistry, University of California, Davis, One Shields Avenue, Davis, California 95616, USA.
| | | | | | | | | | | |
Collapse
|
19
|
Abstract
Natural products have been the mainstay of cancer chemotherapy for the past 30 years. However, the quickening pace of (aberrant) gene identification, and the new technologies of combinatorial chemistry and high-throughput screening, should provide access to a wide range of new, totally synthetic drugs. Will these new approaches sound the death knell for therapies based on natural products? In reality, natural products are likely to provide many of the lead structures, and these will be used as templates for the construction of novel compounds with enhanced biological properties.
Collapse
Affiliation(s)
- John Mann
- Queen's University Belfast, David Keir Building, Belfast BT9 5AG, Northern Ireland.
| |
Collapse
|
20
|
Abstract
[structure: see text]. Several conformationally rigid analogues of the methylvalerate subunit contained within the linker domain of the antitumor antibiotic bleomycin have been prepared. These compounds have been protected in a fashion suitable for the solid-phase synthesis of bleomycin. Bleomycin congeners containing these analogues should facilitate a more detailed understanding of the nature of the conformational bend that the methylvalerate moiety is thought to impart to the natural product.
Collapse
Affiliation(s)
- M J Rishel
- Department of Chemistry, University of Virginia, Charlottesville, 22901, USA
| | | |
Collapse
|
21
|
Affiliation(s)
- S Hashimoto
- Departments of Chemistry and Biology University of Virginia, Charlottesville, Virginia 22901, USA
| | | | | |
Collapse
|
22
|
Hall DG, Manku S, Wang F. Solution- and solid-phase strategies for the design, synthesis, and screening of libraries based on natural product templates: a comprehensive survey. JOURNAL OF COMBINATORIAL CHEMISTRY 2001; 3:125-50. [PMID: 11300852 DOI: 10.1021/cc0001001] [Citation(s) in RCA: 140] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- D G Hall
- Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2 Canada.
| | | | | |
Collapse
|